{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:57:40Z","timestamp":1792623460228,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005915","name":"Tata Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11725-x","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:51:30Z","timestamp":1775220690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A genome-edited isogenic human embryonic stem cell model of pompe disease recapitulates cardiac and skeletal muscle pathology"],"prefix":"10.1007","volume":"53","author":[{"given":"Vibhaa Kokkanda","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasanth","family":"Thamodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"11725_CR1","doi-asserted-by":"crossref","unstructured":"Meena NK, Raben N (2020) Pompe disease: new developments in an old lysosomal storage disorder. Biomolecules, 10(9), p.1339","DOI":"10.3390\/biom10091339"},{"key":"11725_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neuroscience.2024.09.043","volume":"563","author":"W Kong","year":"2024","unstructured":"Kong W, Lu C, Wang L (2024) Global birth prevalence of Pompe disease: A systematic review and meta-analysis. Neuroscience 563:167\u2013174","journal-title":"Neuroscience"},{"issue":"3","key":"11725_CR3","first-page":"210","volume":"11","author":"M Nicolino","year":"2009","unstructured":"Nicolino M, Byrne B, Wraith JE, Leslie N, Mandel H, Freyer DR, Arnold GL, Pivnick EK, Ottinger CJ, Robinson PH, Loo JCA (2009) Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease. Genet Sci 11(3):210\u2013219","journal-title":"Genet Sci"},{"issue":"5","key":"11725_CR4","first-page":"267","volume":"8","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, Case LE, Crowley JF, Downs S, Howell RR, Kravitz RM, Mackey J (2006) Pompe disease diagnosis and management guideline. Genet Sci 8(5):267\u2013288","journal-title":"Genet Sci"},{"issue":"24","key":"11725_CR5","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/hmg\/ddr424","volume":"20","author":"HP Huang","year":"2011","unstructured":"Huang HP, Chen PH, Hwu WL, Chuang CY, Chien YH, Stone L, Chien CL, Li LT, Chiang SC, Chen HF, Ho HN (2011) Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Hum Mol Genet 20(24):4851\u20134864","journal-title":"Hum Mol Genet"},{"issue":"1","key":"11725_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymgme.2014.02.012","volume":"112","author":"T Higuchi","year":"2014","unstructured":"Higuchi T, Kawagoe S, Otsu M, Shimada Y, Kobayashi H, Hirayama R, Eto K, Ida H, Ohashi T, Nakauchi H, Eto Y (2014) The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-\u03b1-glucosidase in Pompe\u2019s iPSCs. Mol Genet Metab 112(1):44\u201348","journal-title":"Mol Genet Metab"},{"issue":"5","key":"11725_CR7","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1074\/jbc.M114.628628","volume":"290","author":"KK Raval","year":"2015","unstructured":"Raval KK, Tao R, White BE, De Lange WJ, Koonce CH, Yu J, Kishnani PS, Thomson JA, Mosher DF, Ralphe JC, Kamp TJ (2015) Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes. J Biol Chem 290(5):3121\u20133136","journal-title":"J Biol Chem"},{"issue":"2","key":"11725_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","volume":"11","author":"J-A Lim","year":"2015","unstructured":"Lim J-A, Li L, Kakhlon O, Myerowitz R, Raben N (2015) Defects in calcium homeostasis and mitochondria can be reversed in Pompe disease. Autophagy 11(2):385\u2013402. https:\/\/doi.org\/10.1080\/15548627.2015.1009779","journal-title":"Autophagy"},{"issue":"1","key":"11725_CR9","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-017-14063-y","volume":"7","author":"T Yoshida","year":"2017","unstructured":"Yoshida T, Awaya T, Jonouchi T, Kimura R, Kimura S, Era T, Heike T, Sakurai H (2017) A skeletal muscle model of infantile-onset Pompe disease with patient-specific iPS cells. Sci Rep 7(1):13473","journal-title":"Sci Rep"},{"issue":"1","key":"11725_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42003-021-02059-4","volume":"4","author":"J Wang","year":"2021","unstructured":"Wang J, Zhou CJ, Khodabukus A, Tran S, Han SO, Carlson AL, Madden L, Kishnani PS, Koeberl DD, Bursac N (2021) Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease. Commun Biology 4(1):524","journal-title":"Commun Biology"},{"issue":"3","key":"11725_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/scd.2008.0131","volume":"18","author":"MS Inamdar","year":"2009","unstructured":"Inamdar MS, Venu P, Srinivas MS, Rao K, VijayRaghavan K (2009) Derivation and characterization of two sibling human embryonic stem cell lines from discarded grade III embryos. Stem Cells Dev 18(3):423\u2013434","journal-title":"Stem Cells Dev"},{"issue":"1","key":"11725_CR12","doi-asserted-by":"publisher","first-page":"18498","DOI":"10.1038\/s41598-020-73656-2","volume":"10","author":"N Balafkan","year":"2020","unstructured":"Balafkan N, Mostafavi S, Schubert M, Siller R, Liang KX, Sullivan G, Bindoff LA (2020) A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates. Sci Rep 10(1):18498","journal-title":"Sci Rep"},{"issue":"3","key":"11725_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.stemcr.2014.07.001","volume":"3","author":"M Shelton","year":"2014","unstructured":"Shelton M, Metz J, Liu J, Carpenedo RL, Demers SP, Stanford WL, Skerjanc IS (2014) Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells. Stem Cell Rep 3(3):516\u2013529","journal-title":"Stem Cell Rep"},{"key":"11725_CR14","doi-asserted-by":"publisher","first-page":"101621","DOI":"10.1016\/j.scr.2019.101621","volume":"41","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Li A, Wang J, Wang G, Wang D (2019) Generation of induced pluripotent stem cells (iPSCs) from an infant with Pompe disease carrying with compound mutations of R608X and E888X in GAA gene. Stem Cell Res 41:101621","journal-title":"Stem Cell Res"},{"issue":"5","key":"11725_CR15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.stemcr.2022.03.019","volume":"17","author":"IR Brooks","year":"2022","unstructured":"Brooks IR, Garrone CM, Kerins C, Kiar CS, Syntaka S, Xu JZ, Spagnoli FM, Watt FM (2022) Functional genomics and the future of iPSCs in disease modelling. Stem Cell Rep 17(5):1033\u20131047","journal-title":"Stem Cell Rep"},{"key":"11725_CR16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jpeds.2019.08.058","volume":"216","author":"N Gupta","year":"2020","unstructured":"Gupta N, Kazi ZB, Nampoothiri S, Jagdeesh S, Kabra M, Puri RD, Muranjan M, Kalaivani M, Rehder C, Bali D, Verma IC (2020) Clinical and molecular disease spectrum and outcomes in patients with infantile-onset Pompe disease. J Pediatr 216:44\u201350","journal-title":"J Pediatr"},{"key":"11725_CR17","doi-asserted-by":"crossref","unstructured":"Forcina L, Cosentino M, Musar\u00f2 A (2020) Mechanisms regulating muscle regeneration: insights into the interrelated and time-dependent phases of tissue healing. Cells, 9(5), p.1297","DOI":"10.3390\/cells9051297"},{"key":"11725_CR18","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","volume":"122","author":"L Sala","year":"2018","unstructured":"Sala L, van Meer BJ, Tertoolen LGJ, Bakkers J, Bellin M, Davis RP, Denning C, Dieben MAE, Eschenhagen T, Giacomelli E, Grandela C, Hansen A, Holman ER, Jongbloed MRM, Kamel SM, Koopman CD, Lachaud Q, Mannhardt I, Mol MPH, Mosqueira D, Orlova VV, Passier R, Ribeiro MC, Saleem U, Smith GL, Burton FL, Mummery CL (2018) MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circul Res 122:e5\u201316","journal-title":"Circul Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11725-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11725-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:51:33Z","timestamp":1775220693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11725-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11725"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11725-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7423302\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies (TIGS\/IEC\/3\/6\/2025) were reviewed and approved by the ethics committee of the Tata Institute for Genetics and Society.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"587"}}